Rising cost of ‘specialty’ drugs prompts employers to limit their use When Kathi Ryness’s multiple sclerosis worsened in 2000, she began taking Avonex, a drug that helps slow the progression of the disease and reduces the number of relapses. At the time, her health plan covered the drug in full.
Source: Washington Post Posted on:
Tuesday, May 08, 2012, 8:30am Views: 1196